These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 11314007)
1. Tumor specific modulation of KU70/80 DNA binding activity in breast and bladder human tumor biopsies. Pucci S; Mazzarelli P; Rabitti C; Giai M; Gallucci M; Flammia G; Alcini A; Altomare V; Fazio VM Oncogene; 2001 Feb; 20(6):739-47. PubMed ID: 11314007 [TBL] [Abstract][Full Text] [Related]
2. Expression and DNA binding activity of the Ku heterodimer in bladder carcinoma. Stronati L; Gensabella G; Lamberti C; Barattini P; Frasca D; Tanzarella C; Giacobini S; Toscano MG; Santacroce C; Danesi DT Cancer; 2001 Nov; 92(9):2484-92. PubMed ID: 11745306 [TBL] [Abstract][Full Text] [Related]
3. Papillary and muscle invasive bladder tumors with distinct genomic stability profiles have different DNA repair fidelity and KU DNA-binding activities. Bentley J; L'Hôte C; Platt F; Hurst CD; Lowery J; Taylor C; Sak SC; Harnden P; Knowles MA; Kiltie AE Genes Chromosomes Cancer; 2009 Apr; 48(4):310-21. PubMed ID: 19105236 [TBL] [Abstract][Full Text] [Related]
4. Differential modulation of Ku70/80 DNA-binding activity in a patient with multiple basal cell carcinomas. Mazzarelli P; Rabitti C; Parrella P; Seripa D; Persichetti P; Marangi GF; Perrone G; Poeta ML; Delfino M; Fazio VM J Invest Dermatol; 2003 Sep; 121(3):628-33. PubMed ID: 12925225 [TBL] [Abstract][Full Text] [Related]
5. Up-regulation of DNA-dependent protein kinase activity and Sp1 in colorectal cancer. Hosoi Y; Watanabe T; Nakagawa K; Matsumoto Y; Enomoto A; Morita A; Nagawa H; Suzuki N Int J Oncol; 2004 Aug; 25(2):461-8. PubMed ID: 15254745 [TBL] [Abstract][Full Text] [Related]
6. Disruption of DNA-PK in Ku80 mutant xrs-6 and the implications in DNA double-strand break repair. Chen F; Peterson SR; Story MD; Chen DJ Mutat Res; 1996 Jan; 362(1):9-19. PubMed ID: 8538653 [TBL] [Abstract][Full Text] [Related]
7. DNA-PK-dependent phosphorylation of Ku70/80 is not required for non-homologous end joining. Douglas P; Gupta S; Morrice N; Meek K; Lees-Miller SP DNA Repair (Amst); 2005 Aug; 4(9):1006-18. PubMed ID: 15941674 [TBL] [Abstract][Full Text] [Related]
8. Ku70/Ku80 protein complex inhibits the binding of nucleotide excision repair proteins on linear DNA in vitro. Frit P; Calsou P; Chen DJ; Salles B J Mol Biol; 1998 Dec; 284(4):963-73. PubMed ID: 9837719 [TBL] [Abstract][Full Text] [Related]
9. Double-strand break repair by Ku70 requires heterodimerization with Ku80 and DNA binding functions. Jin S; Weaver DT EMBO J; 1997 Nov; 16(22):6874-85. PubMed ID: 9362500 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of KU70/KU80, a key DNA damage repair protein in breast cancer. Alshareeda AT; Negm OH; Albarakati N; Green AR; Nolan C; Sultana R; Madhusudan S; Benhasouna A; Tighe P; Ellis IO; Rakha EA Breast Cancer Res Treat; 2013 Jun; 139(2):301-10. PubMed ID: 23624778 [TBL] [Abstract][Full Text] [Related]
11. DNA-dependent protein kinase phosphorylation sites in Ku 70/80 heterodimer. Chan DW; Ye R; Veillette CJ; Lees-Miller SP Biochemistry; 1999 Feb; 38(6):1819-28. PubMed ID: 10026262 [TBL] [Abstract][Full Text] [Related]
12. Specific interaction of IP6 with human Ku70/80, the DNA-binding subunit of DNA-PK. Hanakahi LA; West SC EMBO J; 2002 Apr; 21(8):2038-44. PubMed ID: 11953323 [TBL] [Abstract][Full Text] [Related]
13. Ku70 can translocate to the nucleus independent of Ku80 translocation and DNA-PK autophosphorylation. Koike M; Shiomi T; Koike A Biochem Biophys Res Commun; 2000 Oct; 276(3):1105-11. PubMed ID: 11027597 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated heat-activated antisense Ku70 expression radiosensitizes tumor cells in vitro and in vivo. Li GC; He F; Shao X; Urano M; Shen L; Kim D; Borrelli M; Leibel SA; Gutin PH; Ling CC Cancer Res; 2003 Jun; 63(12):3268-74. PubMed ID: 12810658 [TBL] [Abstract][Full Text] [Related]
15. A central region of Ku80 mediates interaction with Ku70 in vivo. Cary RB; Chen F; Shen Z; Chen DJ Nucleic Acids Res; 1998 Feb; 26(4):974-9. PubMed ID: 9461456 [TBL] [Abstract][Full Text] [Related]
16. DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumor. Mazzarelli P; Parrella P; Seripa D; Signori E; Perrone G; Rabitti C; Borzomati D; Gabbrielli A; Matera MG; Gravina C; Caricato M; Poeta ML; Rinaldi M; Valeri S; Coppola R; Fazio VM World J Gastroenterol; 2005 Nov; 11(42):6694-700. PubMed ID: 16425368 [TBL] [Abstract][Full Text] [Related]
17. Assembly and DNA binding of recombinant Ku (p70/p80) autoantigen defined by a novel monoclonal antibody specific for p70/p80 heterodimers. Wang J; Satoh M; Pierani A; Schmitt J; Chou CH; Stunnenberg HG; Roeder RG; Reeves WH J Cell Sci; 1994 Nov; 107 ( Pt 11)():3223-33. PubMed ID: 7699019 [TBL] [Abstract][Full Text] [Related]
18. Human normal peripheral blood B-lymphocytes are deficient in DNA-dependent protein kinase activity due to the expression of a variant form of the Ku86 protein. Muller C; Dusseau C; Calsou P; Salles B Oncogene; 1998 Mar; 16(12):1553-60. PubMed ID: 9569022 [TBL] [Abstract][Full Text] [Related]
19. Radioresistance in a tumour cell line correlates with radiation inducible Ku 70/80 end-binding activity. Negroni A; Stronati L; Grollino MG; Barattini P; Gumiero D; Danesi DT Int J Radiat Biol; 2008 Apr; 84(4):265-76. PubMed ID: 18386192 [TBL] [Abstract][Full Text] [Related]
20. Differential etoposide sensitivity of cells deficient in the Ku and DNA-PKcs components of the DNA-dependent protein kinase. Jin S; Inoue S; Weaver DT Carcinogenesis; 1998 Jun; 19(6):965-71. PubMed ID: 9667732 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]